140 related articles for article (PubMed ID: 9246604)
1. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
[TBL] [Abstract][Full Text] [Related]
2. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
[TBL] [Abstract][Full Text] [Related]
3. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
5. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line.
Dupuis F; Levasseur S; Jean-Louis F; Dulery C; Praloran V; Denizot Y; Michel L
Biochim Biophys Acta; 1997 Dec; 1359(3):241-9. PubMed ID: 9434130
[TBL] [Abstract][Full Text] [Related]
6. Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.
Kudo I; Kato T; Hayashi H; Yanoshita R; Ikizawa K; Uda H; Inoue K
Lipids; 1991 Dec; 26(12):1065-70. PubMed ID: 1668106
[TBL] [Abstract][Full Text] [Related]
7. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
8. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
9. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Thielman NM; Marcinkiewicz M; Sarosiek J; Fang GD; Guerrant RL
J Clin Invest; 1997 Apr; 99(8):1999-2004. PubMed ID: 9109445
[TBL] [Abstract][Full Text] [Related]
13. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor and haematopoiesis. XI. Platelet-activating factor has no effect on the production of interleukin-6 and tumor necrosis factor-alpha by human bone marrow stromal cells.
Denizot Y; Rougier F; Cornu E; Praloran V
Eur Cytokine Netw; 1996; 7(1):75-7. PubMed ID: 8704099
[TBL] [Abstract][Full Text] [Related]
15. PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells.
Denizot Y; Dupuis F; Trimoreau F; Verger C; Allegraud A; Praloran V
J Lipid Mediat Cell Signal; 1996 Dec; 15(1):1-4. PubMed ID: 9029369
[TBL] [Abstract][Full Text] [Related]
16. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
18. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
[TBL] [Abstract][Full Text] [Related]
19. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
20. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival.
Zhu P; DeCoster MA; Bazan NG
J Neurosci Res; 2004 Aug; 77(4):525-31. PubMed ID: 15264222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
